ORCHPHARMA — Orchid Pharma Share News
0.000.00%
- IN₹49.30bn
- IN₹51.52bn
- IN₹12.32bn
Brief: Orchid Pharma Dec-qtr loss narrows
Brief: Orchid Pharma Sept-qtr loss narrows
UK drugs regulator to halt approvals for Indian clinical trials firm (updated)
UK drugs regulator halts approvals for Indian clinical trials firm
Brief: Orchid Pharma gets Establishment Inspection Report from USFDA for Alathur API facility
Brief: Orchid Pharma gets final USFDA nod for Rasagiline Generic Formulation
Brief: Orchid Pharma received the EIR from USFDA
Brief: Orchid Pharma says Orchid Europe entered into financial arrangement for up to $800 mln
Indian stocks to watch-Dec 6
Indian stocks to watch-Dec 6